Partner Therapeutics, Inc. (PTx), a private, fully-integrated biotechnology company announced today that the New England Journal ...

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a ...

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025(Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodi ...

Journal of Nuclear Medicine Technology January 2025, jnmt.124.268665; DOI: https://doi.org/10.2967/jnmt.124.268665 ...

Frank L. Dini; Ryan T. Demmer; Anca Simioniuc; Doralisa Morrone; Francesca Donati; Giacinta Guarini; Enrico Orsini; Paolo Caravelli; Mario Marzilli; Paolo C. Colombo ...

Coronary angiograms in both patients showed TIMI grade 0 flow in the proximal left anterior descending artery (A, G). Both patients underwent primary percutaneous coronary intervention, which ...

A failing left ventricle cannot accommodate the increased ... persistent orthopnea was associated with failure of improvement of LVEF and increased risk of hospitalization. We have shown that ...

The term dilated cardiomyopathy (DCM) refers to a spectrum of heterogeneous myocardial disorders that are characterized by ventricular dilation and depressed myocardial performance in the absence of ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when ...